Compare SLE & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLE | CLGN |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 4.9M |
| IPO Year | 2019 | 2015 |
| Metric | SLE | CLGN |
|---|---|---|
| Price | $2.97 | $0.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $60.00 | $11.00 |
| AVG Volume (30 Days) | 34.3K | ★ 77.7K |
| Earning Date | 05-14-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,064,000.00 | N/A |
| Revenue This Year | $24.86 | $240.45 |
| Revenue Next Year | $49.77 | $38.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 90.41 | N/A |
| 52 Week Low | $0.48 | $0.27 |
| 52 Week High | $11.43 | $3.23 |
| Indicator | SLE | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 44.59 |
| Support Level | $0.51 | $0.31 |
| Resistance Level | $3.43 | $0.45 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 12.00 | 39.81 |
Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.